Cardiovascular

Cardiovascular areas we support

The cardiovascular areas we work in, and how our regulatory, clinical, reimbursement and commercial teams support companies in each.

Structural Heart

Transcatheter and surgical therapies for valve and structural disease, adopted through heart teams.

Structural heart devices treat valvular disease and other structural abnormalities through transcatheter and surgical approaches. Adoption runs through multidisciplinary heart teams and depends on imaging, procedural planning, operator experience, hospital capability and follow-up protocols.

How we support

  • Regulatory Affairs

    PMA and IDE strategy for Class III implants, including label expansion into new anatomies and risk groups.

  • Clinical Operations

    Pivotal IDE studies with heart-team screening, independent eligibility review and core-laboratory imaging.

  • Reimbursement & Market Access

    National coverage requirements for TAVR, mitral repair, appendage closure and tricuspid therapies, including registry participation, alongside facility and physician payment.

  • Commercial Strategy & Execution

    Adoption through structural heart programs: referral pathways, case proctoring and procedural planning support.

Technologies includeTranscatheter aortic valve replacement · Transcatheter mitral and tricuspid repair and replacement · Left atrial appendage closure · Septal defect and PFO closure · Surgical valves and annuloplasty · Embolic protection and procedural imaging

Heart Failure & Circulatory Support

Acute mechanical support, durable devices and remote management across critical care and outpatient follow-up.

This segment covers technologies for acute and chronic heart failure: temporary mechanical circulatory support, durable support systems and monitoring or care-management approaches. They involve different patient populations, care settings, procedural demands and economic models.

How we support

  • Regulatory Affairs

    Pathways for temporary support, durable devices and implantable monitors, from 510(k) to PMA.

  • Clinical Operations

    Studies in acutely ill populations and outcomes studies for durable support and remote management.

  • Reimbursement & Market Access

    Inpatient economics for mechanical support, ventricular assist device coverage (NCD 20.9.1) and payment for remote monitoring.

  • Commercial Strategy & Execution

    Adoption across shock teams, advanced heart failure programs and outpatient follow-up.

Technologies includeTemporary percutaneous ventricular support · Extracorporeal membrane oxygenation systems · Durable left ventricular assist devices · Implantable hemodynamic monitoring · Device-based heart failure therapies · Remote patient management

Coronary Intervention

Catheter-based treatment and assessment of coronary artery disease in a high-volume, contracted cath lab market.

Coronary intervention covers technologies used to diagnose and treat coronary artery disease through catheter-based procedures, from implants and drug-coated balloons to lesion preparation, intravascular imaging, physiology and tools for complex percutaneous coronary intervention.

How we support

Technologies includeDrug-eluting stents and scaffolds · Drug-coated balloons · Intravascular lithotripsy and atherectomy · Intravascular imaging (IVUS and OCT) · Coronary physiology · Guides, wires and complex PCI tools

Electrophysiology & Rhythm Management

Ablation, mapping, implantable rhythm devices and monitoring, each with distinct workflows and buyers.

This segment covers ablation technologies, mapping and navigation systems, implantable rhythm-management devices and cardiac monitoring. These categories differ in clinical workflow, evidence requirements, purchasing structure and reimbursement.

How we support

  • Regulatory Affairs

    PMA and 510(k) strategy across ablation, mapping, implantable rhythm devices and monitors.

  • Clinical Operations

    Ablation and device studies with procedural, rhythm and durability endpoints.

  • Reimbursement & Market Access

    Coding and payment for ablation, implant and remote monitoring services, and coverage requirements for implantable defibrillators.

  • Commercial Strategy & Execution

    Capital and disposable models across EP labs, device clinics and remote monitoring services.

Technologies includePulsed field, radiofrequency and cryoablation · Electroanatomic mapping and navigation · Pacemakers, leadless and conduction system pacing · Implantable cardioverter-defibrillators · Insertable cardiac monitors · Remote device monitoring

Cardiac Surgery & Perfusion

Capital equipment, disposables and surgical technologies evaluated by surgery, perfusion and operating-room leadership.

Cardiac surgery and perfusion encompass technologies used during cardiopulmonary bypass and related surgical procedures, including heart-lung machines, oxygenators, perfusion disposables, monitoring systems and surgical implants. Commercial requirements differ between capital equipment, recurring disposables, procedural technologies and software.

How we support

Technologies includeHeart-lung machines and perfusion systems · Oxygenators, circuits and cannulae · Surgical valves, rings and grafts · Surgical ablation and appendage exclusion · Myocardial protection and blood management · Intraoperative monitoring

Cardiovascular Imaging, Monitoring & Diagnostics

Technologies that characterize the heart and inform decisions, from imaging and physiology to ambulatory monitoring and software.

Cardiovascular imaging, monitoring and diagnostic technologies characterize cardiac structure or function, measure physiologic parameters, detect cardiovascular conditions, support clinical decisions and monitor patients across acute, procedural and ambulatory settings.

How we support

Technologies includeEchocardiography and intracardiac echo · Cardiac CT and CT-derived physiology · Cardiac MRI and nuclear imaging · ECG and ambulatory rhythm monitoring · Hemodynamic monitoring · AI-enabled analysis software

Vascular & Peripheral Intervention

Endovascular and surgical technologies across arterial, aortic and venous disease, often used in several sites of care.

Vascular and peripheral intervention covers technologies used in endovascular procedures and the treatment of peripheral arterial, aortic and venous disease. Products vary by anatomy, procedure, setting, user and whether they are implantable, disposable, capital-based or software-enabled.

How we support

Technologies includePeripheral drug-coated balloons and stents · Atherectomy and intravascular lithotripsy · Aortic stent grafts · Venous thrombectomy and venous stents · Carotid revascularization · Embolic protection and closure devices

Working on a cardiovascular device?

Tell us about the technology and where it is in development.